These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8060750)

  • 41. Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.
    Santin AD; Zhan F; Bignotti E; Siegel ER; Cané S; Bellone S; Palmieri M; Anfossi S; Thomas M; Burnett A; Kay HH; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Virology; 2005 Jan; 331(2):269-91. PubMed ID: 15629771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The expression of c-myc protein in uterine cervical cancer: a possible prognostic indicator].
    Wu HJ
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):515-21. PubMed ID: 8754393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The c-myc proto-oncogene in invasive carcinomas of the uterine cervix: clinical relevance of overexpression in early stages of the cancer.
    Riou GF; Bourhis J; Le MG
    Anticancer Res; 1990; 10(5A):1225-31. PubMed ID: 2173473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance.
    Mitra S; Mazumder Indra D; Bhattacharya N; Singh RK; Basu PS; Mondal RK; Roy A; Zabarovsky ER; Roychoudhury S; Panda CK
    Genes Chromosomes Cancer; 2010 Feb; 49(2):155-70. PubMed ID: 19885927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amplification of the c-myc proto-oncogene in cervical carcinoma.
    Baker VV; Hatch KD; Shingleton HM
    J Surg Oncol; 1988 Dec; 39(4):225-8. PubMed ID: 3193767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppressor of cytokine signaling (SOCS) genes are silenced by DNA hypermethylation and histone deacetylation and regulate response to radiotherapy in cervical cancer cells.
    Kim MH; Kim MS; Kim W; Kang MA; Cacalano NA; Kang SB; Shin YJ; Jeong JH
    PLoS One; 2015; 10(4):e0123133. PubMed ID: 25849377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix.
    Riou G; Barrois M; Lê MG; George M; Le Doussal V; Haie C
    Lancet; 1987 Apr; 1(8536):761-3. PubMed ID: 2882179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells.
    Singh S; Kumar PU; Thakur S; Kiran S; Sen B; Sharma S; Rao VV; Poongothai AR; Ramakrishna G
    Tumour Biol; 2015 Aug; 36(8):6159-71. PubMed ID: 25794641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The possibility of viral etiology in cervical carcinogenesis].
    Iwasaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):802-11. PubMed ID: 2172417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer.
    Pedroza-Torres A; Campos-Parra AD; Millan-Catalan O; Loissell-Baltazar YA; Zamudio-Meza H; Cantú de León D; Montalvo-Esquivel G; Isla-Ortiz D; Herrera LA; Ángeles-Zaragoza Ó; Robelo-Romero G; Herrera-Gómez Á; Pérez-Plasencia C
    Oncol Rep; 2018 Mar; 39(3):1532-1540. PubMed ID: 29399698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long non-coding RNAs and cervical cancer.
    Aalijahan H; Ghorbian S
    Exp Mol Pathol; 2019 Feb; 106():7-16. PubMed ID: 30471246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An integrative functional genomic and gene expression approach revealed SORBS2 as a putative tumour suppressor gene involved in cervical carcinogenesis.
    Backsch C; Rudolph B; Steinbach D; Scheungraber C; Liesenfeld M; Häfner N; Hildner M; Habenicht A; Runnebaum IB; Dürst M
    Carcinogenesis; 2011 Jul; 32(7):1100-6. PubMed ID: 21602178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endocervical carcinoma and precursor lesions: c-myc expression and the demonstration of field changes.
    Polacarz SV; Darne J; Sheridan EG; Ginsberg R; Sharp F
    J Clin Pathol; 1991 Nov; 44(11):896-9. PubMed ID: 1752978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oncogenes and radiation carcinogenesis.
    Garte SJ; Burns FJ
    Environ Health Perspect; 1991 Jun; 93():45-9. PubMed ID: 1773800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
    Xu R; Hu J; Zhang T; Jiang C; Wang HY
    Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytometric evidence that cervical intraepithelial neoplasia I and II are dysplasias rather than true neoplasias. An image analysis study of factors involved in the progression of cervical lesions.
    Mariuzzi G; Santinelli A; Valli M; Sisti S; Montironi R; Mariuzzi L; Alberti R; Pisani E
    Anal Quant Cytol Histol; 1992 Apr; 14(2):137-47. PubMed ID: 1590897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth.
    Liu Y; Murray-Stewart T; Casero RA; Kagiampakis I; Jin L; Zhang J; Wang H; Che Q; Tong H; Ke J; Jiang F; Wang F; Wan X
    Int J Oncol; 2017 Jun; 50(6):2011-2023. PubMed ID: 28498475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p73 expression is associated with the cellular radiosensitivity in cervical cancer after radiotherapy.
    Liu SS; Leung RC; Chan KY; Chiu PM; Cheung AN; Tam KF; Ng TY; Wong LC; Ngan HY
    Clin Cancer Res; 2004 May; 10(10):3309-16. PubMed ID: 15161684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.